# Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome

> **NCT00565903** · — · COMPLETED · sponsor: **Ashley Hill** · enrollment: 1247 (actual)

## Conditions studied

- Pleuropulmonary Blastoma
- Cystic Nephroma
- Sertoli-Leydig Cell Tumor of Ovary
- Medulloepithelioma
- Embryonal Rhabdomyosarcoma of Cervix
- Goiter
- Sarcoma
- Pineoblastoma
- Pituitary Tumors
- Wilms Tumor

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00565903
- **Lead sponsor:** Ashley Hill
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2018-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 1247 (ACTUAL)
- **Last updated:** 2023-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00565903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00565903, "Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00565903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
